Back to Newsroom

International Stem Cell Corporation to Present at the Rodman and Renshaw Global Investment Conference

CARLSBAD, CA–(Marketwired – September 01, 2015) – International Stem Cell Corporation (OTCQB: ISCO)(, ISCO or the Company), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that Ruslan Semechkin, PhD, board member and chief scientific officer, will provide a company overview and update on development of clinical and research programs at the Rodman and Renshaw 17th Annual Global Investment Conference:

Date: Wednesday, September 9, 2015
Time: 03:00 p.m. ET
Location: The St. Regis Hotel, New York
Room: Astor Suite A

Click here to read more